Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Maxim -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (11)	1/25/2000 8:44:00 AM
From: biowa	Read Replies (1) \| Respond to of 24

Walter, SAN DIEGO--(BW HealthWire)--Jan. 25, 2000--Maxim Pharmaceuticals Inc. (AMEX:MMP)(SSE:MAXM) today announced the filing of a registration statement with the Securities and Exchange Commission for an offering of 2.5 million shares of its common stock.<snip> J.P. Morgan & Co. is acting as lead manager for this offering. Prudential Vector Healthcare Group, a unit of Prudential Securities, and Aragon Securities AB are acting as co-managers.<snip> Looks like more confirmation that the window is open. They've had a pattern of doing private convertibles and then converting them, now they're going directly to the public market. If the market responds as it has over the last several weeks, forget about dilution effect. Sidebar: Folks at Chase H&Q can't be too happy about this one getting away. biowa